Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INNOSPEC INC.IOSP · Entity 4414 | Head of Group Finance | February 23, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INNOSPEC INC.
Report date February 23, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security · Expires 2029-02-23 | Direct | 520 |
Reported balance
After 2026-02-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-23 · Grant · Acquired 520 · Balance 520 F1: Each share of phantom stock is the economic equivalent of one share of Innospec common stock. The award is scheduled to automatically settle in cash on the Expiration Date based on the closing price of Innospec common stock on that date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of Innospec common stock. The award is scheduled to automatically settle in cash on the Expiration Date based on the closing price of Innospec common stock on that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 25, 2026 22:42 UTC | INNOSPEC INC. IOSP · Entity 4414 | GrantPhantom Stock · Derivative | 520 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072257 · ownership.xml · derivative · entry 1 Blair Graeme · CIK 0001816235 · Head of Group Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520 Underlying: Common Stock · 520 shares Expires 2029-02-23 F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Innospec common stock. The award is scheduled to automatically settle in cash on the Expiration Date based on the closing price of Innospec common stock on that date. Read SEC document |
| February 24, 2025 Filed Feb 28, 2025 01:50 UTC | INNOSPEC INC. IOSP · Entity 4414 | GrantPhantom Stock · Derivative | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-029424 · ownership.xml · derivative · entry 1 Blair Graeme · CIK 0001816235 · Head of Group Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2028-02-24 F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Innospec common stock. The award is settled in cash on the Expiration Date based on the closing price of Innospec stock on that date. Read SEC document |
| February 26, 2024 Filed Feb 29, 2024 01:57 UTC | INNOSPEC INC. IOSP · Entity 4414 | GrantPhantom Stock · Derivative | 228 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022539 · ownership.xml · derivative · entry 1 Blair Graeme · CIK 0001816235 · Head of Group Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228 Underlying: Common Stock · 228 shares Expires 2027-02-26 F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of IOSP common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.